These results are consistent with earlier studies, predominantly centered on patients with DM in secondary prevention studies, that indicated an association between elevated Lp(a) levels and an increased incidence of adverse cardiovascular outcomes [17–19]. This evidence concerns the gene LPA and diabetes mellitus.